<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Diabetes and Metabolic Disorders</JournalTitle><Volume>6</Volume><Issue>0</Issue></Journal><ArticleTitle>TO DETERMINE THE EFFECTS OF SOY CONSUMPTION ON MARKERS OF INFLAMMATION AND ENDOTHELIAL FUNCTION IN POSTMENOPAUSAL WOMEN WITH THE METABOLIC SYNDROME.</ArticleTitle><FirstPage>190</FirstPage><LastPage>190</LastPage><AuthorList><Author><FirstName>Leila</FirstName><LastName>Azadbakht</LastName></Author><Author><FirstName>Masoud</FirstName><LastName>Kimiagar</LastName></Author><Author><FirstName>Yadolah</FirstName><LastName>Mehrabi</LastName></Author><Author><FirstName>Ahmad</FirstName><LastName>Esmaeil Zadeh</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>05</Day></PubDate></History><Abstract>Background: Recently on the metabolic syndrome is considered as an inflammatory disease. So factors affecting inflammation are important in this condition.
Methods: This randomized cross-over clinical trial was undertaken on 42 postmenopausal women with metabolic syndrome. Participants were randomly assigned to consume a control diet (Dietary Approaches to Stop Hypertension= DASH), soy protein diet, or soy nut diet, each for eight weeks. Inflammatory markers were measured by ELISA.
&amp;nbsp;Results: The difference from the control diet for E-selectin (an inflammatory markers which shows the endothelial function) was -11.4% (P&amp;lt;0.01) on the soy nut consumption and -4.7% (p=0.19) on the soy protein diets. Soy nut consumption reduced interleukin-18 compared to the control diet (difference from the control diet: -9.2%, p&amp;lt;0.01). For C-reactive protein the difference from the control diet was -8.9% (P&amp;lt;0.01) on the soy nut diet and -1.6% (P&amp;lt;0.01) on the soy protein diet.
Conclusion: Short-term soy nut consumption reduced some markers of inflammation and increased plasma nitric oxide levels in postmenopausal women with the metabolic syndrome.</Abstract><web_url>https://jdmd.tums.ac.ir/index.php/jdmd/article/view/190</web_url></Article></Articles>
